Grace Therapeutics Inc. Common Stock (GRCE)
Stock · NASDAQ · Health Care
$1.87as of 10/16/2026
Price chart
Active signals
GRCE Signal Track Record
How signals performed across all stocks →What GRCE's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 41 | -2.2% | 49% | October 1, 2026 |
| Bollinger Band Breakout | 28 | -3.0% | 32% | September 10, 2026 |
| Bollinger Band BreakdownActive now | 18 | -4.7% | 39% | July 29, 2026 |
| 200-Day Moving Average TouchActive now | 13 | -2.3% | 46% | October 2, 2025 |
| Any 20-session window (baseline) | -1.0% | 45% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About GRCE
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 5
- Website
- www.gracetx.com/
Fundamentals
- 1-day range
- $1.89$1.97
- Market cap
- $28.44M
- P/E (trailing)
- —
- P/E (forward)
- -4.33
- EPS (trailing)
- $-1.18
- Dividend yield
- —
- Beta
- 0.36
- Avg. volume
- 166.4K
Forecasts
2 analyst ratings
Grace Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- GRCEGrace Therapeutics Inc. Common Stock$1.89▼ 3.08%Market cap $28.44MP/E —$1.79$5.18
- MIRAMIRA Pharmaceuticals Inc. Common Stock$0.632▼ 3.95%Market cap $28.50MP/E —$0.6$2.45
- RMTIRockwell Medical Inc. Common Stock$7.43▼ 6.89%Market cap $28.26MP/E —$4.89$12.9
- KYNBKyntra Bio Inc. Common Stock$4.85▼ 9.51%Market cap $28.26MP/E 0.12$5.34$11.65
- ACTUActuate Therapeutics Inc. Common stock$0.605▲ 21.00%Market cap $29.43MP/E —$0.41$8.27
- ABVCABVC BioPharma Inc. Common Stock$0.918▼ 1.61%Market cap $27.09MP/E —$0.7069$3.07
- BCTXBriaCell Therapeutics Corp. Common Shares$3.4▼ 9.81%Market cap $30.01MP/E —$3.68$20.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GRCE Grace Therapeutics Inc. Common Stock | $28.44M | — | $1.89 | ▼ 3.08% | $1.79$5.18 |
| MIRA MIRA Pharmaceuticals Inc. Common Stock | $28.50M | — | $0.632 | ▼ 3.95% | $0.6$2.45 |
| RMTI Rockwell Medical Inc. Common Stock | $28.26M | — | $7.43 | ▼ 6.89% | $4.89$12.9 |
| KYNB Kyntra Bio Inc. Common Stock | $28.26M | 0.12 | $4.85 | ▼ 9.51% | $5.34$11.65 |
| ACTU Actuate Therapeutics Inc. Common stock | $29.43M | — | $0.605 | ▲ 21.00% | $0.41$8.27 |
| ABVC ABVC BioPharma Inc. Common Stock | $27.09M | — | $0.918 | ▼ 1.61% | $0.7069$3.07 |
| BCTX BriaCell Therapeutics Corp. Common Shares | $30.01M | — | $3.4 | ▼ 9.81% | $3.68$20.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Opaleye Management Inc. · October 5, 2026 · Buy1.7K @ $2.06
- Opaleye Management Inc. · October 2, 2026 · Buy20.0K @ $2.07
- Opaleye Management Inc. · October 1, 2026 · Buy38.8K @ $2.04
- Opaleye Management Inc. · September 29, 2026 · Buy7.8K @ $2.09
- Opaleye Management Inc. · September 23, 2026 · Buy5.3K @ $2.1
- Opaleye Management Inc. · September 21, 2026 · Buy9.8K @ $2.1
- Vimal Kavuru · September 17, 2026 · Grant12.2K
- NEUGEBOREN EDWARD · September 17, 2026 · Grant12.2K
- DAVIS A BRIAN · September 17, 2026 · Grant0
- Kottayil George · September 17, 2026 · Grant12.2K
- Opaleye Management Inc. · September 9, 2026 · Buy5.8K @ $2.09
- Kohli Prashant · September 9, 2026 · Buy100.0K @ $2.14
- Opaleye Management Inc. · September 8, 2026 · Buy9.4K @ $2.1
- Kohli Prashant · August 28, 2026 · Grant267.2K
- Kumar Amresh · August 28, 2026 · Grant35.8K
Institutional Ownership
March 31, 2026
- Total shares held
- 4.37M
- Total value held
- $20.23M
- Institutional holders
- 34
- Unknown849.1K
- Unknown756.6K
- Unknown728.2K
- Unknown494.7K
- Unknown401.7K
- Unknown243.9K
- Unknown167.1K
- Unknown112.8K
- Unknown98.7K
- Unknown91.4K
See the full, filterable feed with live charts on the MarketWall dashboard.